`
`—————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`—————
`
`SLAYBACK PHARMA LLC,
`Petitioner,
`
`v.
`
`EYE THERAPIES, LLC,
`Patent Owner.
`
`—————
`
`Case No.: IPR2022-00142
`
`U.S. Patent No.: 8,293,742
`
`—————
`
`PETITIONER’S UPDATED MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`Pursuant to 37 C.F.R. § 42.8, Petitioner Slayback Pharma LLC hereby
`
`submits the following updated mandatory notices.
`
`I.
`
`REAL PARTY-IN-INTEREST (37 C.F.R. § 42.8(b)(1)) (Updated)
`
`Petitioner identifies Slayback Pharma LLC, Slayback Pharma India LLP, Dr.
`
`Reddy’s Laboratories S.A. and Dr. Reddy’s Laboratories, Inc. as real parties-in-
`
`interest.
`
`II.
`
`RELATED MATTERS
`
`In parallel with this proceeding, Petitioner submitted a Petition for IPR of
`
`U.S. Patent No. 9,259,425 (“the ‘425 patent”) (IPR2022-00146), which was
`
`instituted and placed on the same schedule as this proceeding.
`
`Except as detailed above, to the best of Petitioner’s knowledge, the ‘425
`
`patent and the ‘742 patent have not been the subject of any prior Petition for IPR.
`
`Patent Owner has asserted the ‘742 patent in the following litigations:
`
`Bausch & Lomb Inc. et al. v. Slayback Pharma LLC et al., 3:21-cv-16766 (D.N.J.),
`
`and Bausch & Lomb, Inc. et al. v. Lupin Limited et al., 3:22-cv-00534 (D.N.J.).
`
`To the best of Petitioner’s knowledge, the ‘742 patent has not been asserted
`
`in any other litigations.
`
`III.
`
`IDENTIFICATION OF COUNSEL AND SERVICE
`INFORMATION
`
`Lead Counsel: Linnea P. Cipriano (Reg. No. 67,729; Tel. 212-813-8800;
`
`Fax 212- 237-2204; lcipriano@goodwinlaw.com) attorney at Goodwin Procter
`
`1
`
`
`
` LLP, 620 Eighth Avenue, New York, NY 10018.
`
`Backup Counsel: Louis H. Weinstein (Reg. No. 45,205; Tel. 973.966.3236;
`
`Cell 201-463-1964; Fax 973-966-3250; lweinstein@windelsmarx.com), attorney at
`
`Windels Marx Lane & Mittendorf, LLP, 1 Giralda Farms, Madison, NJ 07940.
`
`Patrick G. Pollard (Reg. No. 64,084; Tel. 973.966.3249; Cell 201-259-1679;
`
`Fax 973-966-3250; ppollard@windelsmarx.com), attorney at Windels Marx Lane
`
`& Mittendorf, LLP, 1 Giralda Farms, Madison, NJ 07940.
`
`Robert Frederickson III (Pro hac vice application to be filed, Tel. (617) 570-
`
`1947; Cell 973-229-6925; Fax 617-321-4472; rfrederickson@goodwinlaw.com),
`
`attorney at Goodwin Procter LLP, 100 Northern Ave, Boston, MA 02210.
`
`IV.
`
`SERVICE INFORMATION
`
`Please direct all correspondence to counsel at the contact information above.
`
`Petitioner consents to service by electronic mail at
`
`DG-BrimonidineIPRs@goodwinlaw.com, lweinstein@windelsmarx.com, and
`
`ppollard@windelsmarx.com.
`
`Dated: August 5, 2022
`
`Respectfully submitted,
`
`By: /Linnea P. Cipriano/
`Linnea P. Cipriano
`(Reg. No. 67,729)
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`
`2
`
`
`
`Phone: (212) 813-8800
`Fax: (212) 937-2204
`lcipriano@goodwinlaw.com
`
`Counsel for Petitioner Slayback
`Pharma LLC
`
`3
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing
`
`PETITIONER’S UPDATED MANDATORY NOTICES TO 37 C.F.R. § 42.8 was
`
`served on August 5, 2022, by electronic mail to:
`
`Bryan Diner bryan.diner@finnegan.com
`Justin Hasford Justin.hasford@finnegan.com
`Caitlin O’Connell caitlin.oconnell@finnegan.com
`Christina Yang christina.yang@finnegan.com
`
`Respectfully submitted,
`
`
`
`/Linnea P. Cipriano/
`Linnea P. Cipriano
`(Reg. No. 67,729)
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`Phone: (212) 813-8800
`Fax: (212) 937-2204
`lcipriano@goodwinlaw.com
`
`Counsel for Petitioner Slayback
`Pharma LLC
`
`4
`
`